Synthesis, characterization and Mossbauer studies of Fe(II) and Fe(III) complexes of 2-acetylpyridine thiosemicarbazone.

被引:0
|
作者
Borges, RHU
Abras, A
Beraldo, H
机构
[1] UNIV FED MINAS GERAIS,ICEX,DEPT QUIM,BR-31270901 BELO HORIZONT,MG,BRAZIL
[2] UNIV FED MINAS GERAIS,ICEX,DEPT FIS,BR-31270901 BELO HORIZONT,MG,BRAZIL
关键词
2-acetylpyridine thiosemicarbazone; iron complexes;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Three iron complexes of 2-acetylpyridine thiosemicarbazone were obtained, namely [Fe(HAPT)(APT)]Cl-2 (I), [Fe(HAPT)(2)]Cl-2 (II), and [Fe(APT)(2)] (III), in which HAPT stands for the ligand protonated at the N(2') level in the side chain and APT(-) for the ligand deprotonated at N(2'). The coordination to the metal ion occurs through the tridentate ligating N-py boolean AND N(1')) boolean AND (S), system with formation of 2:1 ligand-to-metal complexes having meridional stereochemistry. The Mossbauer parameters delta (isomer shift) and Delta (quadrupole splitting) are characteristic of Fe(III) for complex I and of Fe(II) for both complexes II and III, all low spin with octahedral geometry. The isomer shift value decreases in going from [Fe(HAPT)(2)]Cl-2 (II, delta = 0.264 +/- 0.001 mm/s) to [Fe(APT)(2)] (III, delta = 0.227 +/- 0.001 mm/s), due to the higher s electron density of the latter. This results from the electron donor inductive effect of the acetyl methyl group and the negative charge of the thiolate sulfur, which is consequently a better sigma donor than the thione sulfur. The quadrupole splitting increases in going from II (Delta = 0.537 +/- 0.002 mm/s) to III (Delta = 0.755 +/- 0.002 mm/s), probably due to ligand inequivalencies, a significant contribution being attributed to differences in the metal-ligand bond order.
引用
收藏
页码:33 / 38
页数:6
相关论文
共 50 条
  • [1] Synthesis and characterization of nickel(II) complexes of 2-acetylpyridine thiosemicarbazone
    Alphonsa, CK
    Kurup, MRP
    SYNTHESIS AND REACTIVITY IN INORGANIC AND METAL-ORGANIC CHEMISTRY, 1999, 29 (05): : 805 - 815
  • [2] Synthesis and characterization of iron(III) complexes of a substituted 2-acetylpyridine thiosemicarbazone
    Garg, BS
    Kurup, MRP
    Jain, SK
    Bhoon, YK
    SYNTHESIS AND REACTIVITY IN INORGANIC AND METAL-ORGANIC CHEMISTRY, 1998, 28 (08): : 1415 - 1426
  • [3] IRON(III) COMPLEXES OF 2-ACETYLPYRIDINE THIOSEMICARBAZONE
    RAINA, R
    SRIVASTAVA, TS
    INDIAN JOURNAL OF CHEMISTRY SECTION A-INORGANIC BIO-INORGANIC PHYSICAL THEORETICAL & ANALYTICAL CHEMISTRY, 1983, 22 (08): : 701 - 703
  • [4] SPECTROPHOTOMETRIC DETERMINATION OF VANADIUM WITH 2-ACETYLPYRIDINE THIOSEMICARBAZONE.
    Bhaskare, C.K.
    Devi, Surekha
    Indian Journal of Technology, 1985, 23 (10): : 393 - 394
  • [5] CHARACTERIZATION OF NICKEL(II) COMPLEXES OF A SUBSTITUTED 2-ACETYLPYRIDINE THIOSEMICARBAZONE BY ELECTRONIC AND NMR SPECTRAL STUDIES
    GARG, BS
    KURUP, MRP
    JAIN, SK
    BHOON, YK
    TRANSITION METAL CHEMISTRY, 1991, 16 (01) : 111 - 113
  • [6] NICKEL(II) COMPLEXES OF A THIOSEMICARBAZONE PREPARED FROM 2-ACETYLPYRIDINE
    WEST, DX
    SCOVILL, JP
    SILVERTON, JV
    BAVOSO, A
    TRANSITION METAL CHEMISTRY, 1986, 11 (04) : 123 - 131
  • [7] SPECTROSCOPIC STUDIES ON COPPER(II) COMPLEXES DERIVED FROM A SUBSTITUTED 2-ACETYLPYRIDINE THIOSEMICARBAZONE
    GARG, BS
    KURUP, MRP
    JAIN, SK
    BHOON, YK
    TRANSITION METAL CHEMISTRY, 1988, 13 (04) : 309 - 312
  • [8] Mn(II), Co(II), Zn(II), Fe(III) and U (VI) complexes of 2-acetylpyridine 4N-(2-pyridyl) thiosemicarbazone (HAPT); structural, spectroscopic and biological studies
    El-Ayaan, Usama
    Youssef, Magdy M.
    Al-Shihry, Shar
    JOURNAL OF MOLECULAR STRUCTURE, 2009, 936 (1-3) : 213 - 219
  • [9] Synthesis and structural studies of gallium(III) and indium(III) complexes of 2-acetylpyridine thiosemicarbazones
    Chan, Jessica
    Thompson, Amber L.
    Jones, Michael W.
    Peach, Josephine M.
    INORGANICA CHIMICA ACTA, 2010, 363 (06) : 1140 - 1149
  • [10] Platinum(II) and palladium(II) complexes with 2-acetylpyridine thiosemicarbazone: cytogenetic and antineoplastic effects
    Iakovidou, Z
    Papageorgiou, A
    Demertzis, MA
    Mioglou, E
    Mourelatos, D
    Kotsis, A
    Yadav, PN
    Kovala-Demertzi, D
    ANTI-CANCER DRUGS, 2001, 12 (01) : 65 - 70